A carregar...
Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and HCC, among patients with HCV Results from ERCHIVES
BACKGROUND: Statins are associated with delayed fibrosis progression and a reduced risk of hepatocellular carcinoma (HCC) in chronic hepatitis C virus (HCV). Limited data exist regarding the most effective type and dose of statin in this population. We sought to determine the impact of statin type a...
Na minha lista:
| Publicado no: | Hepatology |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4917438/ https://ncbi.nlm.nih.gov/pubmed/26891205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28506 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|